Tampilkan postingan dengan label System. Tampilkan semua postingan
Tampilkan postingan dengan label System. Tampilkan semua postingan

Rabu, 16 Agustus 2017

Effect Of HIV On Neurological System


Today's post from zedie.wordpress.com (see link below) talks about something that is causing arguments for and against across the scientific world. Along with aging more quickly, if you have HIV, the incidence of neurological disorders (including dementia, memory loss, Alzheimers and Parkinsons and of course neuropathy) amongst HIV positive people is said to be both higher and occurs sooner, than in the general population. It's difficult to prove, which is why there are many who disagree but as far as neuropathy is concerned, when 30% to 40% of HIV carriers have neuropathic problems, those are pretty convincing statistics. The problem is that just as many diabetes patients end up with neuropathy, so restricting it to HIV patients is somewhat tenuous.




The Effect of HIV on Neurologic Disorders.
Source: Journal Watch Infectious Diseases Nov.22nd 2012

In a large cohort study, HIV-positive men developed neurologic disorders at an earlier age and more frequently than HIV-negative men.

The incidence of many neurologic complications of HIV infection has fallen dramatically since effective combination antiretroviral therapy (ART) was introduced in 1996. To determine whether HIV infection continues to have an effect on neurologic disorders during the era of combination ART, investigators studied a large cohort of men followed between July 1996 and June 2011 in the Multicenter AIDS Cohort Study.

HIV-positive (n=1862) and HIV-negative (n=2169) men who have sex with men were included in the analyses. In the HIV-positive men, the median CD4 count was 585 cells/mm3, and the average duration of ART use was 10.6 years. The incidence of neurologic disorders was higher in HIV-positive men than in HIV-negative men. The median age of first neurologic diagnosis was 48 in the HIV-positive men compared with 57 in the HIV-negative ones. Peripheral nerve and muscle disorders (the most common diagnoses), nervous system infections, dementia, and seizures were more common in HIV-infected than in HIV-negative men; when only confirmed cases were counted, stroke was not more common in the HIV-infected group. Although this study took place during the era of effective therapy, 21% of HIV-infected patients with a neurologic disorder were not receiving ART at the time of the complication.

Comment: This study suggests that HIV infection may increase the rate — and perhaps accelerate the development — of neurologic disorders. However, the relevance of these findings to patients who are doing well on current therapy is difficult to know. A substantial fraction of patients who developed neurologic complications were not receiving ART, and, of those on treatment, we are not told what proportion had virologic suppression. Moreover, the development of some diagnoses in this study, such as peripheral neuropathy, may have been exacerbated by antiretrovirals that we no longer use (e.g., stavudine, didanosine). Also, because ascertainment of neurologic conditions in this study was based on medical record review, more recently recognized and subtle entities, such as mild neurocognitive disorder, were not included. Nevertheless, this study highlights the importance of following HIV-infected patients closely for neurologic disorders and emphasizes the need to initiate effective ART before such complications develop.



http://zedie.wordpress.com/2012/11/22/the-effect-of-hiv-on-neurologic-disorders/

Kamis, 18 Mei 2017

Educating The Nervous System To Ignore Pain


Today's post from pbs.org (see link below) is an excellent explanation of the complexity of chronic pain as a condition and how modern drugs are frequently ineffective in dealing with it. The need is for new drug compounds to address new neural receptors but although progress is being made, it will still take a very long time before the processes and drugs can be explored and refined. It is thought that by interrupting the signal between the pain and the brain (to put it very simply) there is a brief period when old pain memories can be erased. It's working in this area that may bring the most progress for nerve damage patients in the future. A fascinating article - definitely worth a read.

Teaching the Nervous System to Forget Chronic PainBy Eleanor Nelsen on Wed, 13 Aug 2014
“It was an emergency situation,” she says. The horse Sally was riding was barreling straight towards another, younger horse, and the only way to stop him was to pull back on one rein, hard. She felt a pop in her wrist. Heat shot up her arm, excruciating pain fast on its heels.

That was four years ago. No one knows quite what happened to her wrist that day, but whatever it was has left her with constant pain that stretches from her fingertips to her neck, and sometimes creeps into her ribs. On the really bad days, even a hug is unbearably painful.

Sally is my youngest sister, and she is one of an unlucky fraction of people for whom an injury catapults their nervous system into a state of chronic pain. The injury itself heals, but like an insidious memory, the pain lingers. We don’t know why. “The whole issue of the transition from acute pain to chronic pain—why some individuals develop that chronic pain and many don’t—is a major, major question,” says Allan Basbaum, a professor at the University of California, San Francisco. Genetics may play a role. So can the severity of the original injury. 

Today's painkillers are based on well-known compounds like morphine and are often highly addictive.

But what we do know is that once that pain has gotten a foothold, doctors and patients don’t have very many choices. “The irony is that morphine, the 2,000-year-old drug, still remains the number-one weapon against pain,” says Yves De Koninck, a professor of neuroscience at Université Laval in Canada.

And it’s not a weapon that anyone enjoys using. Opioids like morphine and oxycodone are famously addictive, and the numbers of people who abuse them are climbing. Painkiller overdoses now kill more people than cocaine and heroin combined. And while opioids are invaluable for acute pain, they’re less effective for persistent, chronic pain. In fact—in a particularly cruel irony—long-term opioid treatment can actually make pain worse. Non-opioid pain medications exist, but they don’t work for the majority of patients, and even then they are only partly effective. Chronic pain is like “a maladaptive memory.”

Opioids work so well for acute pain because they bind to the receptors the body has designed for its own painkillers—molecules like endorphins and dynorphins that blunt the pain response. Finding good alternatives to opioids for treating chronic pain will mean finding different neurological mechanisms to target—mechanisms that explain not just why people hurt, but why some people hurt for so long.

De Koninck has found such a mechanism. One of the keys to understanding chronic pain, he believes, is to pay attention to the similarities between long-lasting pain and another, very familiar, neurological process that makes some connections stick around longer than others: memory.

Chronic pain is like “a maladaptive memory,” Basbaum explains. Both constitute patterns etched in your brain and nervous system that quicken the connections between “snake” and “poison” or between “bump” and “ouch.” Evidence has been piling up that chronic pain and memory share some of the same cellular mechanisms—and now, De Koninck’s work has shown that a neurochemical trick used to erase memory may be able to turn off chronic pain, too.
An Unmet Need

The number of people struggling with chronic pain has been hotly debated, and the fact that chronic pain is broadly defined and difficult to quantify doesn’t help. But even conservative estimates suggest that about 20% of the population have had at least one episode of serious, chronic pain. In the United States alone, that’s more than 60 million people. “It’s a major unmet need,” De Koninck says.

Pain is physically and psychologically debilitating in way that few other conditions are. “In fact, it’s often the most debilitating component of many diseases,” De Koninck notes. And it sharply circumscribes the lives of people who suffer from it. People can find a way to live with the other challenges of painful conditions like arthritis, cancer, even paralysis, he says, but “if you actually ask the patient, their number-one concern, and the one thing that they want us to cure, is the pain.” When pain pathways are functioning properly, they play a protective role.

When chronic pain gets severe, many patients withdraw, sometimes even from their families. Sally says that she’s constantly nervous, afraid to accept invitations or do things that she loves—like riding horses—in case it makes her arm even worse. The ride that day, Sally says, “changed my life.” For some patients, chronic pain can lead to serious mental health problems—it’s strongly correlated with depression and suicide risk.

When pain pathways are functioning properly, they play a protective role. They are a relay of chemical and electrical signals that move from nerve endings to our brains. Pain teaches us to avoid things that are sharp, prickly, or hot. It’s the way our nervous system has adapted to living in a hazardous world. People who can’t feel any pain typically don’t live very long.

Our skin is packed with millions of specialized nerve endings, programmed to detect dangerous conditions like heat or pressure. When one of these pathways is activated, the neuron sends an electrical current shooting up its long, thin axon towards the spinal cord. When it reaches the end of the neuron, that electrical signal prompts the release of chemicals called neurotransmitters into the synapse, or the gap between the first neuron and the next. The neurotransmitters dock in receptors on the next neuron, triggering pores to open in the cell’s membrane. Charged particles rush in through these open pores, creating a new electrical current that carries the signal farther up the nervous system.
Nerve cells, like these seen here from a mouse's spinal cord, send impulses along their axons and connect over synapses.

The first handoff occurs in a region of the spinal cord known as the dorsal horn, a column of grey matter that looks, in cross-section, like a butterfly. From this first relay point, the signal travels to the thalamus, one of the brain’s switchboards, and eventually to the cerebral cortex, where the signal is processed and decoded.

After an injury, it’s normal for the damage sensors near the trauma site to be touchy for a little while. During that time, your nervous system is encouraging you to protect the damaged tissue while it’s healing. But sometimes that extra sensitivity, called “hyperalgesia,” sticks around long after it’s useful. Hyperalgesia is often a major component of chronic pain, and it means that people with chronic pain have to be unceasingly alert. For example, Sally says, before she hurt her arm, hot coffee sloshing onto her hand might have hurt for a few seconds. Now, a careless moment like that means days of burning pain.

Symptoms like this suggest that changes in the nervous system have migrated to the spinal cord. De Koninck believes that a major factor is the number of receptors on the signal-receiving neurons in the dorsal horn. If those neurons synthesize too many receptors, they’ll pick up too many neurotransmitter molecules. Then the neurons’ pores will flutter open to let charged particles in more often than they should, sending electrical signals shooting up to the brain at too high a frequency. The result is a pain signal that’s much stronger than it should be. De Koninck’s work gives us a new window into how it happens, and how to stop it.
Recall, Then Erase

The key lies in a study about memory that was published nearly 15 years ago. Long-term memories seem to depend on the synthesis of extra receptors, too, and scientists knew that blocking the synthesis of those receptors during a memorable event could keep memories from forming.

But what a group of researchers at New York University discovered was that there is a brief period when interrupting receptor synthesis can actually erase old memories. Memories are reinforced when they’re retrieved, but, paradoxically, during that process, even well-established memories have a brief window of vulnerability—like jewelry in a safe deposit box, memories are useless when they’re stored but accessible to thieves when they’re being used. A chemical called anisomycin blocks the production of receptors that neurons need to form memories. When the researchers injected anisomycin into rats’ brains right after triggering a particular memory, that memory didn’t just fail to get reinforced—it was erased altogether. The right chemical injected at just the right place at just the right time could erase the physiological “memory” of pain.

Accumulating evidence that pain and memory use similar mechanisms led De Koninck to wonder if this same neurochemical trick could erase chronic hyperalgesia. De Koninck and his colleagues made mice hypersensitive to pain by injecting their paws with capsaicin, the chemical responsible for chili peppers’ fiery bite. Capsaicin activates the same pain sensors that respond to extreme heat and can turn on hyperalgesia without the tissue damage that an actual burn would cause. After their capsaicin injection, the mice’s paws were more sensitive to pressure for hours afterward.

Before that sensitivity had had a chance to wear off, the team gave the mice a second capsaicin injection—and this time, they added an injection of anisomycin. What happened after this second injection is “like magic,” De Koninck says. When the second injection initiated the same flurry of neurotransmitters and electrical signals that encoded the hyperalgesia the first time—the pain analogue of recalling a memory—anisomycin shut down the pain-amplifying mechanism by keeping the spinal cord neurons from making extra receptors. “It’s in the process of reorganizing itself,” De Koninck explains, “and there there’s that window of opportunity to actually shut it back down.” The mice lost seventy percent of their hypersensitivity to pain.

The theory that overdeveloped connections other than memories could be attenuated by retriggering them “is not a new idea,” Basbaum says, “but the fact is, there really has been very little evidence that it’s doable.” De Koninck’s results suggest that the right chemical injected at just the right place at just the right time, can erase the physiological “memory” of pain. Ted Price, a professor at the University of Texas-Dallas, says that this “ paves the road to disease modification instead of just palliatively treating people with these terrible drugs like opioids, which everybody, everybody in the field wants to get away from.”
New Options

For now, there are a few other types of treatment doctors can turn to besides opioids. Antidepressants help some people, as do certain antiseizure medications. A controversial technique called “transcutaneous electrical nerve stimulation” may work by making sure that there are plenty of receptors in the dorsal horn for the body’s natural opioid chemicals; a wearable device using this technology was just approved for over-the-counter sale by the FDA.

Treatments based on De Konick’s capsaicin-anisomycin model would constitute an entirely new category of drugs. “When you find a new mechanism,” De Koninck says, “boy, it opens a whole new array of things.” But finding the right combination of chemicals won’t be easy. Capsaicin patches are already sold over the counter at drugstores, but anisomycin is far too indiscriminate for clinical use. Brian Wainger, a physician and researcher at Massachusetts General Hospital, says, “It’s obviously going to be a long time for a discovery like this to work towards a clinical approach, but I think it sort of sets a framework for some options.”

“Options” is a word that seems to come up a lot among pain specialists. One of the reasons chronic pain is so difficult to treat is because “there’s a lot of different forms of chronic pain,” De Koninck says. “But the arsenal that we have so far to treat it is still quite meager.” And the weapons we do have are woefully inadequate.

Still, discovering that this retrigger-and-erase phenomenon works for hyperalgesia, as well as for memory, suggests that it may be useful in other parts of the nervous system. If that’s true, these kinds of treatments could help with pain syndromes more complicated than hyperalgesia—conditions that are so severe that even light touches become painful, or in cases where patients experience pain with no stimulus at all.

One big advantage of De Koninck’s strategy is that it isn’t just an incremental improvement, a way to make a slightly more effective or slightly less addictive analgesic. It’s a totally different angle on the problem. It targets the “chronic” part of chronic pain. “What the field I think really needs is options,” Price says. “And more importantly, patients need options.” For millions of people, and their doctors, a totally different angle is exactly what they’ve been looking for.

Tell us what you think on Twitter #novanext, Facebook, or email.

Eleanor Nelsen
Twitter

Eleanor Nelsen is NOVA's 2014 AAAS Mass Media Fellow. She has also written for QUEST Science and Wisconsin Public Television.

Other posts from this contributor

http://www.pbs.org/wgbh/nova/next/body/chronic-pain

Jumat, 03 Februari 2017

Neuropathy Knowledge What Is The Sensory System


Today's post from sciencedaily.com (see link below) is the eighth part of a series from the same source providing readers with explanations and information about many of the medical terms they hear when researching neuropathy, or sitting in the doctor's surgery and talking about it. Today it explains the 'sensory system' and gives related definitions of other words associated with its workings in the body. Worth following the links if you have the time.


Sensory system
Science Daily via Wikipedia

A sensory system is a part of the nervous system responsible for processing sensory information.
A sensory system consists of sensory receptors, neural pathways, and parts of the brain involved in sensory perception.

Commonly recognized sensory systems are those for vision, hearing, somatic sensation (touch), taste and olfaction (smell). Receptive fields have been identified for the visual system, auditory system and somatosensory system, so far.

For more information about the topic Sensory system, read the full article at Wikipedia.org, or see the following related articles:


Sensory neuron — Sensory neurons are nerve cells within the nervous system responsible for converting external stimuli from the organism's environment into internal ... read more


Nociceptor — A nociceptor is a sensory receptor that sends signals that cause the perception of pain in response to potentially damaging stimulus. Nociceptors are ...  read more


Visual system — The visual system is the part of the nervous system which allows organisms to see. It interprets the information from visible light to build a ... read more


Olfaction — Olfaction, the sense of odor (smell), is the detection of chemicals dissolved in air (or in water, by animals that live under water). In vertebrates ... read more


Psychophysics — Psychophysics is an interdisciplinary field occupying the intersection between cognitive psychology and experimental psychology and dealing with the ... read more


Motion perception — Motion perception is the process of inferring the speed and direction of objects that move in a visual scene given some visual input. While this ...  read more


Thalamus — The thalamus is a part of the brain. The two thalami are located in the center of the brain, one beneath each cerebral hemisphere and next to the ... read more


Pain — Pain's an unpleasant sensation which may be associated with actual or potential tissue damage and which may have physical and emotional components. ...  read more


Hallucination — A hallucination is a sensory perception experienced in the absence of an external stimulus, as distinct from an illusion, which is a misperception of ...  read more


Visual perception — Visual perception is one of the senses, consisting of the ability to detect light and interpret (see) it as the perception known as sight or naked ...  read more

http://www.sciencedaily.com/articles/s/sensory_system.htm

Rabu, 04 Januari 2017

Immune Neuropathy Is Your Immune System Attacking Your Nerves


Today's post from health-innovations.org (see link below) is an interesting one for neuropathy patients whose neuropathy has been diagnosed as, or is suspected of having an auto-immune cause. This especially applies to people with HIV and other auto-immune conditions where the immune system itself attacks the nervous system, causing the symptoms we're all aware of. This article looks at new findings regarding what's causing this and where in the nervous system it's happening. It's technical and goes deeper into the structure of nerves and nerve cells than the average reader will be comfortable with but it's fairly easy to follow and to be honest, you don't need to know all the facts to be able to identify with its conclusions. May be better to talk it over with your neurologist rather than your home doctor, (who may be just as much in the dark as you) but it does give us a reason why certain labels are attached to our version of nerve damage.

Study identifies previously unknown cause of immune neuropathy.
Posted on August 5, 2016 by Healthinnovations 




Patients suffering from so-called immune-mediated neuropathies frequently have a long medical record. As there are no diagnostic tests available to reliably diagnose the disease, the diagnosis is frequently made belatedly and patients can be misdiagnosed. Accordingly, many years often pass before an effective therapy is started. However, not all patients respond to first-choice drugs even when treated immediately. Therefore, identifying biomarkers for this disease is key to early-diagnosis and optimal treatment. Now, a study from researchers at the University of Wuerzburg identifies a new potential trigger of these neuropathies. The team state that they were able to show in patients with antibodies against Caspr, a protein involved in building the myelin sheath, the structure of the Nodes of Ranvier is destroyed and nerve function severely impaired. The study is published in the journal Brain.

Previous studies show that an autoimmune process is believed to cause this neuropathy in which the immune system attacks and destroys components of the nerve fibres. However, exactly how this mechanism works is largely unknown, a fact which makes it more difficult to develop targeted drugs. In the past years, researchers from Spain and Japan have identified autoantibodies against Nodes of Ranvier proteins, such as Contactin-1 and Neurofascin-155, in patients with immune-mediated neuropathies. Caspr is also involved in building the Nodes of Ranvier, therefore, the group decided to investigate this protein. The current study shows that some patients with immune-mediated neuropathies have antibodies against the protein Caspr, which causes the destruction of the Nodes of Ranvier.

The current study examined 35 patients with chronic inflammatory demyelinating polyneuropathy (CIDP), a chronic form of inflammatory nerve disorder, and 22 patients suffering from Guillain-Barré syndrome, an acute form. Results show that in one patient each with CIDP and Guillain-Barré syndrome, antibodies against the protein Caspr were detected in the blood. Data findings show that antibody production in these patients can be inhibited by the drug Rituximab which reverses the symptoms.

Results show that the disease develops rapidly, causes severe paralysis and responds poorly to standard therapy, and responds excellently to Rituximab treatment. Data findings show that strong neuralgia is another typical symptom in patients with Caspr antibodies, as opposed to patients with antibodies against the two other proteins, Neurofascin-155 and Contactin-1, who typically exhibit a distinct tremor in targeted movements.

The team surmise that their findings verify previous studies which show patients who have antibodies against proteins of Nodes of Ranvier exhibit characteristic features. For the future, the researchers state that their study raises hopes for identifying the cause of inflammatory neuropathies in a select subset of patients and that a simple blood test for autoantibodies could provide a targeted treatment.

Source: University of Würzburg




Nodes of Ranvier. Each Schwann cell myelinates about 100 µm of an axon. Gaps between neighboring Schwann cells are called nodes of Ranvier. Action potentials jump from node to node while traversing an axon. Credit: Yale Histology

https://health-innovations.org/2016/08/05/study-identifies-previously-unknown-cause-of-immune-neuropathy/

Kamis, 04 Agustus 2016

Nervous System Problems and Dementia


A few people (possibly more than a few) are clearly worried by the implications of HIV related problems with the nervous system and have asked if neuropathy is a sign of HIV-associated dementia. It seems difficult to associate the one with the other but as this article from aidsinfonet.org, December 2010, (see link below) shows, neuropathy used to be lumped together, along with other nervous system disorders, under the alarming barrier of HIV-associated dementia. The article gives a balanced and informative view and explains that dementia is pretty much a worst-case scenario on the list of various nerve disorders but is by no means inevitable. Many people without HIV develop the same problems as they get older. It's certainly nice to be learning about problems we can face with old age...for many people twenty five years ago, old age was wishful thinking!

Nervous System Problems and Dementia

WHAT ARE NERVOUS SYSTEM PROBLEMS?

The nervous system has two parts. The brain and spinal cord are the central nervous system (CNS). The nerves and muscles are the peripheral (around the outside) nervous system.

People with HIV disease can have several problems with the nervous system. A common problem is peripheral neuropathy. This can cause damage to nerves controlling sensation. Symptoms may include altered sensation, numbness, tingling, pain, or weakness, especially in the feet and legs. Central nervous system (CNS) problems include depression and problems with sleeping, balance, walking, thinking, and memory.

In the early years of AIDS these were all called “HIV-Associated Dementia.” However, a broader range of problems is showing up at present. This is now called HIV-associated Neurological Disturbances (HAND), which includes less severe symptoms referred to as Minor Cognitive Motor Disorder.

Before combination antiretroviral therapy (ART) was available, about 20% of people with AIDS developed severe dementia. Strong antiretroviral medications (ARVs) have cut the rate of serious dementia. However, with longer survival, more people with AIDS are living with milder neurological problems. These are estimated to affect 40% to 70% of people with HIV. This is true even if people are taking ART.

The body has a mechanism to protect the brain from foreign substances. This is called the blood-brain barrier. It keeps most HIV medications from getting into the brain. However, when the viral load in blood goes down, it also goes down in the brain. It is not known whether using HIV drugs that get into the brain helps reduce symptoms of milder neurological problems. Research studies have had mixed results.

WHAT ARE THE SIGNS OF CNS PROBLEMS?

Some neurologic problems require urgent medical attention. If you have serious headaches, especially with a fever, stiff neck, vomiting, or vision problems, or if you develop new weakness or loss of feeling, you should see your health care provider immediately.

The main symptoms of nervous system problems are with thinking, behavior, and movement.

■ Thinking: memory loss, trouble concentrating, mental slowing, trouble understanding. This can include forgetting telephone numbers that you use a lot, having trouble with simple math like making change at the store, People with CNS problems may have difficulty taking their medications on schedule
■ Behavior: Depression, agitation, lack of caring, irritability
■ Movement: Balance problems, unsteady walking, slower movement, poor coordination, tremor

A physical examination may show reduced reflexes in the ankles, especially when compared to reflexes in the knees.

Magnetic Resonance Imaging (MRI,) a radiologic procedure, may show abnormalities in brain tissue.

WHAT MAKES NERVOUS SYSTEM PROBLEMS WORSE?

Many factors can contribute to nervous system problems. These include severe depression, drug and alcohol use, infection with hepatitis C, inflammation and normal aging.

In addition, CNS problems seem to be more common in people with CD4 cell counts below 200, either currently or when they were at their lowest.

As people with HIV are living longer, aging is also contributing to nervous system problems. Some of the problems of aging may show up faster in people with HIV.

HOW ARE CNS PROBLEMS TREATED?

If the side effects of medications include nervous system problems, they usually go away if you stop taking the drugs. This may take as long as several months.

People with CNS problems may have problems with taking their medications on schedule. They may need extra help remembering to take their medications.

Several other neurological problems are emerging in people, even those taking antiviral medications. This includes conditions related to immune reconstitution inflammatory syndrome (IRIS).

THE BOTTOM LINE

HIV disease can cause a wide range of nervous system problems, from forgetfulness and balance problems to serious dementia. These problems usually don’t show up until the later stages of HIV disease. However, problems with memory can show up even in people with no other symptoms.

The new combination therapies that fight HIV seem to protect the central nervous system against the worst damage from the virus. However, because so many more people with HIV are living longer, and getting older, more nervous system problems are showing up.

Caring for someone with serious nervous system problems is very difficult. Caregivers need to take care of themselves, too, to avoid burnout and depression.

http://www.aidsinfonet.org/fact_sheets/view/505?lang=eng